These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8855783)

  • 1. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.
    Grey A; Mitnick MA; Shapses S; Ellison A; Gundberg C; Insogna K
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3450-4. PubMed ID: 8855783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin-6 receptor and biochemical markers of bone metabolism show significant variations during the menstrual cycle.
    Gorai I; Taguchi Y; Chaki O; Kikuchi R; Nakayama M; Yang BC; Yokota S; Minaguchi H
    J Clin Endocrinol Metab; 1998 Feb; 83(2):326-32. PubMed ID: 9467535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
    Insogna K; Mitnick M; Pascarella J; Nakchbandi I; Grey A; Masiukiewicz U
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers.
    Montalbán C; García-Unzueta MT; De Francisco AL; Amado JA
    Horm Metab Res; 1999 Jan; 31(1):14-7. PubMed ID: 10077343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women.
    McKane WR; Khosla S; Peterson JM; Egan K; Riggs BL
    J Bone Miner Res; 1994 Aug; 9(8):1313-8. PubMed ID: 7976512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokines in the changes in bone turnover following bone marrow transplantation.
    Lee WY; Kang MI; Oh ES; Oh KW; Han JH; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
    Osteoporos Int; 2002 Jan; 13(1):62-8. PubMed ID: 11878457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone turnover in prolonged critical illness: effect of vitamin D.
    Van den Berghe G; Van Roosbroeck D; Vanhove P; Wouters PJ; De Pourcq L; Bouillon R
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4623-32. PubMed ID: 14557432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.
    Nakchbandi IA; Lang R; Kinder B; Insogna KL
    J Clin Endocrinol Metab; 2008 Mar; 93(3):967-73. PubMed ID: 18073309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease.
    Valdemarsson S; Lindergård B; Tibblin S; Bergenfelz A
    J Intern Med; 1998 Feb; 243(2):115-22. PubMed ID: 9566639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of simvastatin on serum cytokine levels and bone metabolism in postmenopausal subjects: negative correlation between TNF-alpha and anabolic bone parameters.
    Tikiz C; Unlü Z; Tikiz H; Ay K; Angin A; Onur E; Var A; Tüzün C
    J Bone Miner Metab; 2004; 22(4):365-71. PubMed ID: 15221496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum immunoreactive bone sialoprotein as a new marker of bone turnover in metabolic and malignant bone disease.
    Seibel MJ; Woitge HW; Pecherstorfer M; Karmatschek M; Horn E; Ludwig H; Armbruster FP; Ziegler R
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3289-94. PubMed ID: 8784085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism.
    Hoshino H; Kushida K; Takahashi M; Denda M; Yamazaki K; Yamanashi A; Inoue T
    Miner Electrolyte Metab; 1997; 23(2):93-9. PubMed ID: 9252975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone remodelling markers and serum cytokines in patients with hyperthyroidism.
    Akalin A; Colak O; Alatas O; Efe B
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):125-9. PubMed ID: 12100080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women.
    Charatcharoenwitthaya N; Khosla S; Atkinson EJ; McCready LK; Riggs BL
    J Bone Miner Res; 2007 May; 22(5):724-9. PubMed ID: 17295604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma.
    Abildgaard N; Glerup H; Rungby J; Bendix-Hansen K; Kassem M; Brixen K; Heickendorff L; Nielsen JL; Eriksen EF
    Eur J Haematol; 2000 Feb; 64(2):121-9. PubMed ID: 10997332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.